Instruments

Name Stock exchange Average volume Price Type
PANKAJ POLYMERS LIMITED PANKAJPO

Bombay S.E.

4,286 9 INR Stock Pankaj Polymers Limited Stock
PANKAJ PIYUSH TRADE AND INVESTMENT LIMITED PANKAJPIY6

Bombay S.E.

469 134 INR Stock Pankaj Piyush Trade and Investment Limited Stock

News (38)

Thomas Cook India : Amount credited to IEPF PU
Thomas Cook India : Unclaimed Dividend list as on 23.08.2023 PU
Gabriel India : Interim Dividend –FY 16 PU
Gabriel India : Interim Dividend –FY 17 PU
Rubrik Delivers Cyber Threat Hunting in Battle Against Ransomware GL
Transcript : V.S.T. Tillers Tractors Limited, Q2 2022 Earnings Call, Nov 10, 2021
Goldman Sachs Announces Managing Director Class of 2021 PU
Gabriel India : Unpaid Dividend – FY18 PU
Transcript : V.S.T. Tillers Tractors Limited, Q4 2021 Earnings Call, Jun 22, 2021
MPM Capital : Adds to Senior Team with the Appointment of Oncology Leader Pankaj Bhargava, MD as Executive Partner BU
Praxis Home Retail Limited Announces Resignation of Independent Directors CI
Praxis Home Retail Limited Announces Board Changes CI
Transcript : V.S.T. Tillers Tractors Limited, Q3 2021 Earnings Call, Feb 16, 2021
Transcript : V.S.T. Tillers Tractors Limited, Q2 2021 Earnings Call, Nov 10, 2020
Transcript : PNB Housing Finance Limited, Q1 2021 Earnings Call, Jul 23, 2020
Transcript : PNB Housing Finance Limited, Q4 2020 Earnings Call, Jun 15, 2020
Maruti Suzuki India : lays foundation stone for a Hospital and a School at Sitapur, Gujarat PU
Praxis Home Retail Limited Approves Board Appointments CI
L&T Finance : AGM Proceedings PU
TATA TATA Sons : Steel's Noamundi iron mine awarded Most Innovative Environmental Project Award PU
Dicerna Pharmaceuticals : Announces Dosing of First Patient in Phase 1 Clinical Trial of DCR-PH1 in Patients with Primary Hyperoxaluria Type 1 (PH1) BU
Dicerna Pharmaceuticals : Begins Dosing in First Clinical Trial of Therapy for Primary Hyperoxaluria Type 1 (PH1) in Healthy Volunteers BU
Dicerna Pharmaceuticals : Updates Progress on the Development of DCR-MYC for the Treatment of Solid Tumors BU
Canara Bank Limited Announces Executive Changes CI
Berggruen Institute : Launches Philosophy and Culture Center, and announces the annual $1 million Berggruen Philosophy Prize PR
Dicerna Pharmaceuticals : Submits Investigational New Drug (IND) Application for DCR-PH1, an Investigational Therapy for Primary Hyperoxaluria Type 1 (PH1) BU
Dicerna Pharmaceuticals : Presents Preliminary Safety and Efficacy Data from DCR-MYC Phase 1 Study in Patients with Advanced Solid Tumors at the 2015 ASCO Annual Meeting BU
Dicerna Pharmaceuticals : Announces Expansion of Ongoing DCR-MYC Phase 1 Study to Evaluate Safety and Efficacy in Patients with Advanced Pancreatic Neuroendocrine Tumors (PNETs) BU
Dicerna Pharmaceuticals : to Present Interim Clinical Data from First DCR-MYC Phase 1 Study in Patients with Advanced Solid Tumors at the 2015 ASCO Annual Meeting BU
Dicerna Pharmaceuticals : Announces First Patient Dosed in Phase 1b/2 Clinical Trial of DCR-MYC, an Investigational RNAi Therapeutic Targeting the MYC Oncogene, in Patients with Advanced Hepatocellular Carcinoma BU
Dicerna Pharmaceuticals : Researchers Demonstrate Promise of Dicerna Investigational Therapy in Preclinical Model of Primary Hyperoxaluria Type 1 (PH1) BU
Dicerna Pharmaceuticals : Announces First Quarter 2014 Financial and Operational Results BU
Dicerna Pharmaceuticals : Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) BU
Dicerna Pharmaceuticals : Initiates Phase 1 Study of DCR-MYC in Patients with Solid Tumors and Hematological Malignancies BU
Dicerna Pharmaceuticals : Appoints Dr. Pankaj Bhargava as Chief Medical Officer BU
Dicerna Pharmaceuticals Appoints Pankaj Bhargava as Chief Medical Officer CI
Andhra Cements Announces Board Changes CI
AVEO PHAR : AVEO Pharmaceuticals to Present at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting BU

Insiders


Picture Pankaj Bhargava
Pankaj Bhargava

Pankaj Bhargava is currently a Director at RAL Consumer Products Ltd., People Builders Pvt Ltd., and Coe Creators International Pvt Ltd.
He previously worked as an Independent Director at Praxis Home Retail Ltd.
from 2017 to 2021 and as the Chief Human Resources at Marico Ltd.
from 1991 to 2007.
Bhargava graduated from the Indian Institute of Management Ahmedabad in 1991 and from the Indian Institute of Technology Bombay in 1987.


Picture Pankaj Bhargava
Pankaj Bhargava

Pankaj Bhargava is the founder of Medocity, Inc. founded in 2014, where he holds the title of Advisor.
He currently holds multiple jobs, including Chief Executive Officer at ashibio, Inc., Director at Tizona Therapeutics, Inc., Board Of Director at Presidio Graduate School, and Executive Partner at MPM BioImpact, Inc. Dr. Bhargava's former jobs include Co-Director-Gastrointestinal Oncology Program at University of Massachusetts Medical Center, Chief Medical Officer at Gilead Sciences, Inc., Chief Medical Officer at Dicerna Pharmaceuticals, Inc. from 2014 to 2017, Principal at Dana-Farber Cancer Institute, Inc., Vice President-Clinical Research at AVEO Pharmaceuticals, Inc. from 2006 to 2011, and Associate Vice President at Sanofi-Aventis U.S.
LLC from 2011 to 2014.
He also held the title of Chief Medical Officer at Arch Oncology, Inc. from 2016 to 2017.
Dr. Bhargava received a graduate degree from the University of Delhi.


Picture Pankaj Bhargava
Pankaj Bhargava

Pankaj Bhargava holds the position of President-Procurement at Pidilite Industries Ltd.


Picture Anup Bhargava
Anup Bhargava

Anup Bhargava worked as a Chief Executive Officer at Fedders Electric & Engineering Ltd.
in 2018 and as a Director at India Power Corp.
Ltd.
in 2012.



Picture Sanjeev Bhargava
Sanjeev Bhargava

Sanjeev Bhargava currently works as a Managing Partner at JWT India.


Picture Hemant Bhargava
Hemant Bhargava

Hemant Bhargava was the founder of LIC Cards Services Ltd.
(founded in 2007) and held the title of Chief Executive Officer from 2007 to 2010.
He currently holds the position of Independent Director at ITC Ltd.
(since 2018), Non-Executive Director at Larsen & Toubro Ltd.
(since 2018), and Director at LIC HFL Care Homes Ltd., LIC Pension Fund Ltd., LIC Nomura Mutual Fund Trustee Co. Pvt Ltd., Life Insurance Corp.
(Lanka) Ltd., Ugro Capital Ltd., West End Investment & Finance Consultancy Pvt Ltd., LIC Golden Jubilee Foundation, Providence Life Ltd.
PCC, Lic Bangladesh Ltd., and SMC Global Securities Ltd.
(India) (starting in 2023).
Mr. Bhargava has previously held positions as Non-Executive Chairman at IDBI Bank Ltd.
(in 2019), Infrastructure Leasing & Financial Services Ltd.
(in 2018), and LIC Housing Finance Ltd.
(in 2019).
He was also a Non-Independent Non-Executive Director at Tata Power Co., Ltd.
(from 2017 to 2023), Non-Executive Director at PTC India Ltd.
(from 2010 to 2016), and Non-Independent Non-Executive Director at Voltas Ltd.
(from 2017 to 2021).
Mr. Bhargava has a graduate degree from Jamnalal Bajaj Institute of Management Studies and the University of Lucknow.



No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW